Blood Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels ID: 2014-098
A novel, non-invasive method for monitoring dopamine-related disorders using blood dopamine D2 receptors as biomarkers.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology leverages monocytes in the blood that express dopamine D2 receptors (D2Rs) to serve as a biomarker for brain dopamine levels. This method offers a cost-effective and less invasive alternative to PET scans, providing a valuable tool for diagnosing and monitoring conditions such as Parkinson's disease, psychiatric disorders, and addiction.
Key Advantages
- Non-invasive compared to current PET scan methods
- Cost-effective solution for monitoring dopamine levels
- Enables early diagnosis and monitoring of dopamine-related disorders
- Potential for widespread use in clinical settings
Problems Addressed
- High cost and limited accessibility of PET scans for dopamine monitoring
- Lack of non-invasive diagnostic tools for dopamine-related disorders
- Delayed diagnosis and treatment of psychiatric conditions and addiction
Market Applications
- Diagnostic tool for Parkinson's disease and other dopamine-related disorders
- Monitoring the effectiveness of treatments affecting brain dopamine levels
- Research tool in clinical studies involving dopamine mechanisms
Additional Information
Technology ID: 2014-098
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 07 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report